LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Moors & Cabot, Inc.'s Holding History (CIK: 0001607239)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 12,400 Value ($000) $19 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 12,400 Value ($000) $15 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 12,400 Value ($000) $14 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 12,400 Value ($000) $20 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 12,400 Value ($000) $19 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 12,400 Value ($000) $30 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 18,400 Value ($000) $47 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 23,360 Value ($000) $67 Avg Close $2.59 Range $2.14 - $3.00
Q1 2021
Shares 19,670 Value ($000) $46 Avg Close $2.40 Range $1.55 - $3.13
Q4 2020
Shares 15,750 Value ($000) $27 Avg Close $1.40 Range $0.93 - $2.01
Q3 2020
Shares 14,750 Value ($000) $14 Avg Close $0.88 Range $0.73 - $1.14
Q2 2020
Shares 16,150 Value ($000) $14 Avg Close $0.88 Range $0.70 - $1.20
Q1 2020
Shares 20,150 Value ($000) $15 Avg Close $1.00 Range $0.58 - $1.67
Q4 2019
Shares 20,150 Value ($000) $18 Avg Close $0.83 Range $0.53 - $1.02
Q3 2019
Shares 35,150 Value ($000) $34 Avg Close $1.03 Range $0.82 - $1.26